Epidermal Growth Factor (EGF) treatment on Multipotential Stromal Cells (MSCs). Possible enhancement of therapeutic potential of MSC

Journal of Biomedicine and Biotechnology

Volumn 2010, Issue , 2010, Pages

  Tamama, Kenichi ^a,b   Kawasaki, Haruhisa ^a,b   Wells, Alan ^c,d,e  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d University of Pittsburgh   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; SCATTER FACTOR; VASCULOTROPIN; EPIDERMAL GROWTH FACTOR RECEPTOR;

BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL PROLIFERATION; HUMAN; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PARACRINE SIGNALING; REGENERATIVE MEDICINE; REVIEW; STROMA CELL; TISSUE ENGINEERING; ANIMAL; BIOLOGICAL MODEL; BONE MARROW CELL; CULTURE TECHNIQUE; CYTOLOGY; METABOLISM; METHODOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; BONE MARROW CELLS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; EPIDERMAL GROWTH FACTOR; HUMANS; MESENCHYMAL STEM CELLS; MODELS, BIOLOGICAL; OSTEOGENESIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; STROMAL CELLS;

EID: 77953158654     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2010/795385     Document Type: Review

References (80)

1. F. P. Barry and J. M. Murphy, "Mesenchymal stem cells: clinical applications and biological characterization," International Journal of Biochemistry and Cell Biology, vol. 36, no. 4, pp. 568-584, 2004. (Pubitemid 38324589)
2. D. G. Phinney and D. J. Prockop, "Concise review: mesenchy-mal stem/multipotent stromal cells: the state of transdifferen-tiation and modes of tissue repair-current views," Stem Cells, vol. 25, no. 11, pp. 2896-2902, 2007. (Pubitemid 350127874)
3. K. Tamama, V. H. Fan, L. G. Griffith, H. C. Blair, and A. Wells, "Epidermal growth factor as a candidate for ex vivo expansion of bone marrow-derived mesenchymal stem cells," Stem Cells, vol. 24, no. 3, pp. 686-695, 2006. (Pubitemid 44464773)
4. D. J. Prockop, "Marrow stromal cells as stem cells for nonhematopoietic tissues," Science, vol. 276, no. 5309, pp. 71-74, 1997. (Pubitemid 27161245)
5. M. F. Pittenger, A. M. Mackay, S. C. Beck, et al., "Multilineage potential of adult human mesenchymal stem cells," Science, vol. 284, no. 5411, pp. 143-147, 1999. (Pubitemid 29282067)
6. M. Owen and A. J. Friedenstein, "Stromal stem cells: marrow-derived osteogenic precursors," Ciba Foundation Symposium, vol. 136, pp. 42-60, 1988.
7. T. Kinnaird, E. Stabile, M. S. Burnett, and S. E. Epstein, "Bone marrow-derived cells for enhancing collateral development: mechanisms, animal data, and initial clinical experiences," Circulation Research, vol. 95, no. 4, pp. 354-363, 2004. (Pubitemid 39100453)
8. A. J. Friedenstein, J. F. Gorskaja, and N. N. Kulagina, "Fibrob-last precursors in normal and irradiated mouse hematopoietic organs," Experimental Hematology, vol. 4, no. 5, pp. 267-274, 1976.
9. J. Oswald, S. Boxberger, B. Jørgensen, et al., "Mesenchymal stem cells can be differentiated into endothelial cells in vitro," Stem Cells, vol. 22, no. 3, pp. 377-384, 2004. (Pubitemid 38736621)
10. K. Tamama, C. K. Sen, and A. Wells, "Differentiation of bone marrow mesenchymal stem cells into the smooth muscle lineage by blocking ERK/MAPK signaling pathway," Stem Cells and Development, vol. 17, no. 5, pp. 897-908, 2008.
11. M. F. Pittenger and B. J. Martin, "Mesenchymal stem cells and their potential as cardiac therapeutics," Circulation Research, vol. 95, no. 1, pp. 9-20, 2004. (Pubitemid 38931831)
12. S. Davani, A. Marandin, N. Mersin, et al., "Mesenchymal progenitor cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a rat cellular cardiomyoplasty model," Circulation, vol. 108, no. 10, supplement, pp. II253-II258, 2003. (Pubitemid 37099964)
13. L. C. Amado, A. P. Saliaris, K. H. Schuleri, et al., "Cardiac repair with intramyocardial injection of allogeneic mesenchy-mal stem cells after myocardial infarction," Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 32, pp. 11474-11479, 2005. (Pubitemid 41153844)
14. W. Dai, S. L. Hale, B. J. Martin, et al., "Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short-and long-term effects," Circulation, vol. 112, no. 2, pp. 214-223, 2005. (Pubitemid 40982304)
15. C. Toma, M. F. Pittenger, K. S. Cahill, B. J. Byrne, and P. D. Kessler, "Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart," Circulation, vol. 105, no. 1, pp. 93-98, 2002. (Pubitemid 34049148)
16. T. Ziegelhoeffer, B. Fernandez, S. Kostin, et al., "Bone marrow-derived cells do not incorporate into the adult growing vasculature," Circulation Research, vol. 94, no. 2, pp. 230-238, 2004. (Pubitemid 38197456)
17. Y. Wu, L. Chen, P. G. Scott, and E. E. Tredget, "Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis," Stem Cells, vol. 25, no. 10, pp. 2648-2659, 2007. (Pubitemid 47582758)
18. M. Sasaki, R. Abe, Y. Fujita, S. Ando, D. Inokuma, and H. Shimizu, "Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type," Journal of Immunology, vol. 180, no. 4, pp. 2581-2587, 2008.
19. V. Falanga, S. Iwamoto, M. Chartier, et al., "Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds," Tissue Engineering, vol. 13, no. 6, pp. 1299-1312, 2007. (Pubitemid 46986730)
20. E. H. Javazon, S. G. Keswani, A. T. Badillo, et al., "Enhanced epithelial gap closure and increased angiogenesis in wounds of diabetic mice treated with adult murine bone marrow stromal progenitor cells," Wound Repair and Regeneration, vol. 15, no. 3, pp. 350-359, 2007. (Pubitemid 46817411)
21. T. Kinnaird, E. Stabile, M. S. Burnett, et al., "Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms," Circulation, vol. 109, no. 12, pp. 1543-1549, 2004. (Pubitemid 38420184)
22. G. E. Kilroy, S. J. Foster, X. Wu, et al., "Cytokine profile of human adipose-derived stem cells: expression of angiogenic, hematopoietic, and pro-inflammatory factors," Journal of Cellular Physiology, vol. 212, no. 3, pp. 702-709, 2007. (Pubitemid 47271882)
23. L. Chen, E. E. Tredget, P. Y. G. Wu, Y. Wu, and Y. Wu, "Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing," PLoS ONE, vol. 3, no. 4, article e1886, 2008.
24. T. Schinkothe, W. Bloch, and A. Schmidt, "In vitro secreting profile of human mesenchymal stem cells," Stem Cells and Development, vol. 17, no. 1, pp. 199-205, 2008. (Pubitemid 351271619)
25. M. Gnecchi, H. He, N. Noiseux, et al., "Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement," FASEB Journal, vol. 20, no. 6, pp. 661-669, 2006. (Pubitemid 44933310)
26. A. I. Caplan, "Why are MSCs therapeutic? New data: new insight," Journal of Pathology, vol. 217, no. 2, pp. 318-324, 2009.
27. I. Sekiya, B. L. Larson, J. R. Smith, R. Pochampally, J.-G. Cui, and D. J. Prockop, "Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality," Stem Cells, vol. 20, no. 6, pp. 530-541, 2002. (Pubitemid 35463066)
28. N. Stute, K. Holtz, M. Bubenheim, C. Lange, F. Blake, and A. R. Zander, "Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use," Experimental Hematology, vol. 32, no. 12, pp. 1212-1225, 2004. (Pubitemid 39601127)
29. D. C. Colter, R. Class, C. M. DiGirolamo, and D. J. Prockop, "Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow," Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 7, pp. 3213-3218, 2000. (Pubitemid 30183281)
30. P. R. Crisostomo, M. Wang, G. M. Wairiuko, et al., "High passage number of stem cells adversely affects stem cell activation and myocardial protection," Shock, vol. 26, no. 6, pp. 575-580, 2006. (Pubitemid 44789631)
31. P. A. Sotiropoulou, S. A. Perez, M. Salagianni, C. N. Baxevanis, and M. Papamichail, "Cell culture medium composition and translational adult bone marrow-derived stem cell research," Stem Cells, vol. 24, no. 5, pp. 1409-1410, 2006. (Pubitemid 44464710)
32. F. Ng, S. Boucher, S. Koh, et al., "PDGF, TGF-β, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages," Blood, vol. 112, no. 2, pp. 295-307, 2008.
33. H. Agata, N. Watanabe, Y. Ishii, et al., "Feasibility and efficacy of bone tissue engineering using human bone marrow stromal cells cultivated in serum-free conditions," Biochemical and Biophysical Research Communications, vol. 382, no. 2, pp. 353-358, 2009.
34. E. H. Javazon, K. J. Beggs, and A. W. Flake, "Mesenchymal stem cells: paradoxes of passaging," Experimental Hematology, vol. 32, no. 5, pp. 414-425, 2004. (Pubitemid 38624325)
35. E. M. Horwitz, K. Le Blanc, M. Dominici, et al., "Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement," Cytotherapy, vol. 7, no. 5, pp. 393-395, 2005. (Pubitemid 41671625)
36. D. C. Colter, I. Sekiya, and D. J. Prockop, "Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells," Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 14, pp. 7841-7845, 2001. (Pubitemid 32642648)
37. J. R. Smith, R. Pochampally, A. Perry, S.-C. Hsu, and D. J. Prockop, "Isolation of a highly clonogenic and multipotential subfraction of adult stem cells from bone marrow stroma," Stem Cells, vol. 22, no. 5, pp. 823-831, 2004. (Pubitemid 39166939)
38. R. Pochampally, "Colony forming unit assays for MSCs," Methods in Molecular Biology, vol. 449, pp. 83-91, 2008.
39. S. Jiang, H. Kh. Haider, R. P. H. Ahmed, N. M. Idris, A. Salim, and M. Ashraf, "Transcriptional profiling of young and old mesenchymal stem cells in response to oxygen deprivation and reparability of the infarcted myocardium," Journal of Molecular and Cellular Cardiology, vol. 44, no. 3, pp. 582-596, 2008.
40. S. Cohen and G. A. Elliott, "The stimulation of epidermal keratinization by a protein isolated from the submaxillary gland of the mouse," Journal of Investigative Dermatology, vol. 40, pp. 1-5, 1963.
41. G. Carpenter and S. Cohen, "Epidermal growth factor," Journal of Biological Chemistry, vol. 265, no. 14, pp. 7709-7712, 1990. (Pubitemid 20158927)
42. A. Wells, "EGF receptor," International Journal of Biochemistry and Cell Biology, vol. 31, no. 6, pp. 637-643, 1999. (Pubitemid 29248872)
43. A. Wells, M. F. Ware, F. D. Allen, and D. A. Lauffenburger, "Shaping up for shipping out: PLCγ signaling of morphology changes in EGF-stimulated fibroblast migration," Cell Motility and the Cytoskeleton, vol. 44, no. 4, pp. 227-233, 1999.
44. V. H. Fan, K. Tamama, A. Au, et al., "Tethered epidermal growth factor provides a survival advantage to mesenchymal stem cells," Stem Cells, vol. 25, no. 5, pp. 1241-1251, 2007. (Pubitemid 46684884)
45. M. Krampera, A. Pasini, A. Rigo, et al., "HB-EGF/HER-1 signaling in bone marrow mesenchymal stem cells: inducing cell expansion and reversibly preventing multilineage differentiation," Blood, vol. 106, no. 1, pp. 59-66, 2005. (Pubitemid 40967175)
46. I. Kratchmarova, B. Blagoev, M. Haack-Sorensen, M. Kassem, and M. Mann, "Mechanism of divergent growth factor effects in mesenchymal stem cell differentiation," Science, vol. 308, no. 5727, pp. 1472-1477, 2005. (Pubitemid 40791302)
47. M. O. Platt, A. J. Roman, A. Wells, D. A. Lauffenburger, and L. G. Griffith, "Sustained epidermal growth factor receptor levels and activation by tethered ligand binding enhances osteogenic differentiation of multi-potent marrow stromal cells," Journal of Cellular Physiology, vol. 221, no. 2, pp. 306-317, 2009.
48. R. K. Jaiswal, N. Jaiswal, S. P. Bruder, G. Mbalaviele, D. R. Marshak, and M. F. Pittenger, "Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase," Journal of Biological Chemistry, vol. 275, no. 13, pp. 9645-9652, 2000. (Pubitemid 30185197)
49. R. M. Salasznyk, R. F. Klees, M. K. Hughlock, and G. E. Plopper, "ERK signaling pathways regulate the osteogenic differentiation of human mesenchymal stem cells on collagen I and vitronectin," Cell Communication and Adhesion, vol. 11, no. 5-6, pp. 137-153, 2004. (Pubitemid 41535860)
50. D. F. Ward Jr., R. M. Salasznyk, R. F. Klees, et al., "Mechanical strain enhances extracellular matrix-induced gene focusing and promotes osteogenic differentiation of human mes-enchymal stem cells through an extracellular-related kinase-dependent pathway," Stem Cells and Development, vol. 16, no. 3, pp. 467-479, 2007. (Pubitemid 47016232)
51. T. Okamoto, T. Aoyama, T. Nakayama, et al., "Clonal heterogeneity in differentiation potential of immortalized human mesenchymal stem cells," Biochemical and Biophysical Research Communications, vol. 295, no. 2, pp. 354-361, 2002. (Pubitemid 34785842)
52. K. Satomura, A. R. Derubeis, N. S. Fedarko, et al., "Receptor tyrosine kinase expression in human bone marrow stromal cells," Journal of Cellular Physiology, vol. 177, no. 3, pp. 426-438, 1998. (Pubitemid 28524666)
53. G. L. Brown, L. B. Nanney, J. Griffen, et al., "Enhancement of wound healing by topical treatment with epidermal growth factor," The New England Journal of Medicine, vol. 321, no. 2, pp. 76-79, 1989. (Pubitemid 19170395)
54. J. P. Hong, H. D. Jung, and Y. W. Kim, "Recombinant human epidermal growth factor (EGF) to enhance healing for diabetic foot ulcers," Annals of Plastic Surgery, vol. 56, no. 4, pp. 394-398, 2006.
55. G. Schultz, D. S. Rotatori, and W. Clark, "EGF and TGF-α in wound healing and repair," Journal of Cellular Biochemistry, vol. 45, no. 4, pp. 346-352, 1991.
56. M. Marikovsky, K. Breuing, P. Y. Liu, et al., "Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury," Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 9, pp. 3889-3893, 1993. (Pubitemid 23134131)
57. K. T. Tran, L. Griffith, and A. Wells, "Extracellular matrix signaling through growth factor receptors during wound healing," Wound Repair and Regeneration, vol. 12, no. 3, pp. 262-268, 2004. (Pubitemid 38880434)
58. A. K. V. Iyer, K. T. Tran, L. Griffith, and A. Wells, "Cell surface restriction of EGFR by a tenascin cytotactin-encoded EGF-like repeat is preferential for motility-related signaling," Journal of Cellular Physiology, vol. 214, no. 2, pp. 504-512, 2008. (Pubitemid 350309007)
59. C. S. Swindle, K. T. Tran, T. D. Johnson, et al., "Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor," Journal of Cell Biology, vol. 154, no. 2, pp. 459-468, 2001. (Pubitemid 34288473)
60. E. J. Mackie, W. Halfter, and D. Liverani, "Induction of tenascin in healing wounds," Journal of Cell Biology, vol. 107, no. 6, part 2, pp. 2757-2767, 1988. (Pubitemid 19019409)
61. T. J. Stefonek and K. S. Masters, "Immobilized gradients of epidermal growth factor promote accelerated and directed keratinocyte migration," Wound Repair and Regeneration, vol. 15, no. 6, pp. 847-855, 2007. (Pubitemid 350135232)
62. G. C. Gurtner, S. Werner, Y. Barrandon, and M. T. Longaker, "Wound repair and regeneration," Nature, vol. 453, no. 7193, pp. 314-321, 2008. (Pubitemid 351693137)
63. G. Henry and W. L. Garner, "Inflammatory mediators in wound healing," Surgical Clinics of North America, vol. 83, no. 3, pp. 483-507, 2003. (Pubitemid 36687709)
64. C. K. Sen, "Wound healing essentials: let there be oxygen," Wound Repair and Regeneration, vol. 17, no. 1, pp. 1-18, 2009.
65. P. R. Crisostomo, Y. Wang, T. A. Markel, M. Wang, T. Lahm, and D. R. Meldrum, "Human mesenchymal stem cells stimulated by TNF-α, LPS, or hypoxia produce growth factors by an NFκB-but not JNK-dependent mechanism," American Journal of Physiology, vol. 294, no. 3, pp. C675-C682, 2008. (Pubitemid 351468685)
66. Y. Wang, P. R. Crisostomo, M. Wang, T. A. Markel, N. M. Novotny, and D. R. Meldrum, "TGF-α increases human mesenchymal stem cell-secreted VEGF by MEK-and PI3-K-but not JNK-or ERK-dependent mechanisms," American Journal of Physiology, vol. 295, no. 4, pp. R1115-R1123, 2008.
67. Y. Wang, M. Wang, A. M. Abarbanell, et al., "MEK mediates the novel cross talk between TNFR2 and TGF-EGFR in enhancing vascular endothelial growth factor (VEGF) secretion from human mesenchymal stem cells," Surgery, vol. 146, no. 2, pp. 198-205, 2009.
68. H.-F. Duan, C.-T. Wu, D.-L. Wu, et al., "Treatment of myocardial ischemia with bone marrow-derived mesenchymal stem cells overexpressing hepatocyte growth factor," Molecular Therapy, vol. 8, no. 3, pp. 467-474, 2003. (Pubitemid 37161468)
69. T. Kinnaird, E. Stabile, M. S. Burnett, et al., "Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms," Circulation Research, vol. 94, no. 5, pp. 678-685, 2004. (Pubitemid 38387752)
70. I. Rosová, M. Dao, B. Capoccia, D. Link, and J. A. Nolta, "Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells," Stem Cells, vol. 26, no. 8, pp. 2173-2182, 2008.
71. J. Guan, K. L. Fujimoto, M. S. Sacks, and W. R. Wagner, "Preparation and characterization of highly porous, biodegradable polyurethane scaffolds for soft tissue applications," Biomaterials, vol. 26, no. 18, pp. 3961-3971, 2005. (Pubitemid 40038787)
72. J. Guan, J. J. Stankus, and W. R. Wagner, "Biodegradable elastomeric scaffolds with basic fibroblast growth factor release," Journal of Controlled Release, vol. 120, no. 1-2, pp. 70-78, 2007. (Pubitemid 46874620)
73. M. O. Platt, C. L. Wilder, A. Wells, L. G. Griffith, and D. A. Lauffenburger, "Multipathway kinase signatures of multipo-tent stromal cells are predictive for osteogenic differentiation: tissue-specific stem cells," Stem Cells, vol. 27, no. 11, pp. 2804-2814, 2009.
74. A. A. Mangi, N. Noiseux, D. Kong, et al., "Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts," Nature Medicine, vol. 9, no. 9, pp. 1195-1201, 2003. (Pubitemid 37173705)
75. R. F. Klees, R. M. Salasznyk, K. Kingsley, W. A. Williams, A. Boskey, and G. E. Plopper, "Laminin-5 induces osteogenic gene expression in human mesenchymal stem cells through an ERK-dependent pathway," Molecular Biology of the Cell, vol. 16, no. 2, pp. 881-890, 2005. (Pubitemid 40165579)
76. E. M. Horwitz, P. L. Gordon, W. K. K. Koo, et al., "Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imper-fecta: implications for cell therapy of bone," Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 13, pp. 8932-8937, 2002. (Pubitemid 34693661)
77. E. M. Horwitz, D. J. Prockop, L. A. Fitzpatrick, et al., "Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta," Nature Medicine, vol. 5, no. 3, pp. 309-313, 1999. (Pubitemid 29124367)
78. E. M. Horwitz, D. J. Prockop, P. L. Gordon, et al., "Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta," Blood, vol. 97, no. 5, pp. 1227-1231, 2001. (Pubitemid 32183743)
79. M. Portero-Otin, R. Pamplona, M. J. Bellmunt, et al., "Advanced glycation end product precursors impair epidermal growth factor receptor signaling," Diabetes, vol. 51, no. 5, pp. 1535-1542, 2002. (Pubitemid 34826622)
80. P. O. Prada, E. R. Ropelle, R. H. Mourao, et al., "An EGFR tyrosine-kinase inhibitor (PD153035) improves glucose tolerance and insulin action in high-fat diet-fed mice," Diabetes, vol. 58, no. 12, pp. 2910-2919, 2009.